Comparison Of Renal Dysfunction In Systolic Heart Failure Patients Treated With Sacubitril-Valsartan Or Ace Inhibitor/Angiotensin Receptor Blocker

Nicholas Tan,Yihong Deng,Xiaoxi Yao,LIndsey Sangaralingham,Nilay Shah,Andrew Rule, John Burnett,Shannon Dunlay,Jeson Sangaralingham

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY（2020）

引用 0|浏览8

暂无评分

摘要

Renin-angiotensin-aldosterone system inhibition with ACE inhibitor or angiotensin II receptor blocker (ACEi/ARB) therapy forms the cornerstone of heart failure (HF) management. Emerging clinical trial data suggests that sacubitril-valsartan (neprilysin inhibitor combined with ARB) was associated

查看译文

关键词

systolic heart failure patients,inhibitor/angiotensin receptor blocker,heart failure patients,heart failure,sacubitril-valsartan

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要